Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $1.07 per share versus the Zacks Consensus Estimate of a loss of$ 1.06. This compares to loss of $1.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.94%. A quarter ago, it was expected that this company would post a loss of$ 0.98 per share when it actually produced a loss of $0.79, delivering a surprise of 19.39%.Over the last four quarters, the compan ...